Regulatory/Compliance
Thank you for contacting us; we’ll be in touch shortly.
China Reporting and Compliance Systems: Key Considerations
What makes China compliance so challenging? Watch this brief overview of China’s 3-tier reporting system to help guide your China serialization…
China Q&A: Preparing for New Reporting, Data, and Encoding Requirements
Learn how China’s National Medical Products Administration (NMPA) new reporting requirements and serialization options will affect pharmaceutical…
Are Your Products China Ready? Three Key Decisions for Multinational Pharma Companies
China's drug administration law and serialization framework for medicines could affect your China product packaging strategy. Learn how today.
Will My Current China Reports Work with the New Traceability Systems?
Learn how China’s amended Drug Administration Law expands the scope of NMPA reporting requirements and impacts your company’s serialization strategy.
EDMC or GS1? 3 Keys to Choosing Your China Traceability System Provider
See what companies should consider when choosing between GS1 and EDMS encoding in China, and how that affects their choice of traceability system…
German Biotech Chooses TraceLink Network Over Point-to-Point Approach
Learn why this pharma company opted for TraceLink's multi-tenant solution for compliance and automated validation.
Small Italian CMO Sees Growth Opportunities with TraceLink
Learn why this contract manufacturing organization decided that choosing TraceLink for EU FMD was best for its business goals.
Pharma Drops Vendor over Integration and Validation Failures, Joins TraceLink
One brand owner is now able to make up for lost time, maintain security, and move ahead in their mission to deliver quality and safety. Find out what…
DSCSA and the Path to Supply Chain Transformation for Retail Pharmacies
DSCSA isn't just a requirement for your retail pharmacy, it's an opportunity. Watch this supply chain transformation video to find out why.
DSCSA, Serialization, and the Opportunity for Business Transformation: A Q&A with Novant Health’s Joe Maki
Find out how Novant Health is tackling DSCSA and difficult challenges like recall management and drug shortages.
What Are the 3 Major Requirements of EU FMD?
The EU Falsified Medicines Directive contains requirements for safety features and verification that details how companies must establish…
EU FMD: 3 Key Compliance Challenges for Your Warehouse—and How to Solve Them
Learn three ways EU FMD will change your warehouse standard operating procedures.